Edward Woo

Stock Analyst at Ascendiant Capital

(3.39)
# 1,001
Out of 4,734 analysts
129
Total ratings
43.85%
Success rate
4.79%
Average return

Stocks Rated by Edward Woo

Duos Technologies Group
Dec 17, 2024
Maintains: Buy
Price Target: $6$7.5
Current: $5.90
Upside: +27.12%
Alzamend Neuro
Dec 16, 2024
Maintains: Buy
Price Target: $35$32
Current: $1.19
Upside: +2,589.08%
SurgePays
Dec 16, 2024
Maintains: Buy
Price Target: $9$8.5
Current: $1.52
Upside: +459.21%
Genasys
Dec 16, 2024
Maintains: Buy
Price Target: $4.75$5.5
Current: $2.88
Upside: +90.97%
AIM ImmunoTech
Dec 10, 2024
Maintains: Buy
Price Target: $5$4.5
Current: $0.22
Upside: +1,951.98%
RenovoRx
Dec 10, 2024
Maintains: Buy
Price Target: $8.25$9
Current: $1.54
Upside: +484.42%
Atossa Therapeutics
Dec 9, 2024
Maintains: Buy
Price Target: $6.5$7
Current: $0.87
Upside: +704.69%
Plus Therapeutics
Dec 9, 2024
Maintains: Buy
Price Target: $20$19
Current: $1.24
Upside: +1,432.26%
Lucid Diagnostics
Dec 9, 2024
Maintains: Buy
Price Target: $7.25$7
Current: $0.85
Upside: +723.63%
PAVmed
Dec 9, 2024
Maintains: Buy
Price Target: $21$19
Current: $0.65
Upside: +2,823.08%
Maintains: Buy
Price Target: $8.75$9
Current: $1.52
Upside: +492.11%
Maintains: Buy
Price Target: $14$11
Current: $1.39
Upside: +691.37%
Maintains: Buy
Price Target: $3.75$4
Current: $0.34
Upside: +1,064.82%
Maintains: Buy
Price Target: $2.5$2.75
Current: $1.13
Upside: +143.36%
Maintains: Buy
Price Target: $19$16
Current: $1.29
Upside: +1,140.31%
Maintains: Buy
Price Target: $12$13
Current: $0.70
Upside: +1,770.50%
Maintains: Buy
Price Target: $14$11
Current: $2.24
Upside: +391.07%
Maintains: Buy
Price Target: $44$45
Current: $3.53
Upside: +1,174.79%
Maintains: Buy
Price Target: $8.25$8.5
Current: $11.49
Upside: -26.02%
Maintains: Buy
Price Target: $20$13
Current: $4.77
Upside: +172.54%
Maintains: Buy
Price Target: $8.5$9
Current: $5.99
Upside: +50.25%
Maintains: Buy
Price Target: $8$0.85
Current: $0.71
Upside: +19.52%
Maintains: Buy
Price Target: $800$100
Current: $6.07
Upside: +1,547.45%
Maintains: Buy
Price Target: $18$23
Current: $20.37
Upside: +12.91%
Maintains: Buy
Price Target: $30$52
Current: $44.32
Upside: +17.33%
Maintains: Buy
Price Target: $25$25
Current: $8.22
Upside: +201.16%
Maintains: Buy
Price Target: $35$33
Current: $2.30
Upside: +1,337.91%
Maintains: Buy
Price Target: $20$19
Current: $2.70
Upside: +603.70%
Maintains: Buy
Price Target: $163$125
Current: $1.47
Upside: +8,403.40%
Initiates: Buy
Price Target: $11
Current: $1.17
Upside: +840.17%
Maintains: Buy
Price Target: $17,500$14,000
Current: $6.15
Upside: +227,542.28%
Maintains: Buy
Price Target: $41$38
Current: $28.27
Upside: +34.44%
Maintains: Buy
Price Target: $3,700$3,900
Current: $4,686.41
Upside: -16.78%
Maintains: Buy
Price Target: $133$168
Current: $181.40
Upside: -7.39%
Maintains: Buy
Price Target: $188$200
Current: $11.17
Upside: +1,690.51%
Maintains: Buy
Price Target: $27$30
Current: $15.90
Upside: +88.68%
Maintains: Buy
Price Target: $126$138
Current: $185.14
Upside: -25.46%
Initiates: Buy
Price Target: $330
Current: $3.45
Upside: +9,465.22%
Initiates: Buy
Price Target: $63
Current: $5.61
Upside: +1,014.08%
Maintains: Buy
Price Target: $156$152
Current: $143.28
Upside: +6.09%
Initiates: Buy
Price Target: $24
Current: $1.69
Upside: +1,320.12%
Maintains: Buy
Price Target: $35$30
Current: $10.79
Upside: +178.04%
Maintains: Sell
Price Target: $6$5.75
Current: $27.47
Upside: -79.07%